As breast cancers progress to reach more advanced stages, they secrete higher levels of TGFβ and several chemokines that recruit the N2 subtype, which also respond to IL-10, thereby promoting tumor cell survival, metastasis and angiogenesis. This evidence concerns the gene TGFB1 and neoplasm.